What is personalised medicine (precision medicine)?
Medicine has always sought to provide patients with the most effective treatment for them. However, not every treatment works equally well for every person. Diseases can progress differently, and responses to medicines can also vary significantly. Studies show that response rates to medicines vary greatly depending on the condition and class of active substance, and for some key treatment groups, these rates are sometimes as low as between 50 and 60 per cent.
This is precisely where personalised medicine comes in: precision medicine takes into account individual biological characteristics as well as environmental and lifestyle factors in order to select the most suitable treatments at the right time. This is achieved, amongst other things, through the analysis of genes, molecules and lifestyle habits, which also makes it possible to identify disease risks at an early stage and tailor preventive measures accordingly.
However, this does not necessarily mean that medicines are developed individually for every single person. Patients are often grouped according to specific characteristics, for which different treatment strategies may be appropriate. Biomarkers, which can be detected in blood or tissue, for example, play an important role in this.
Depending on the condition, other factors may also be taken into account. The aim is to better predict which treatment is likely to be effective, to avoid unsuitable therapies wherever possible, and to reduce the risk of side effects.
How does personalised medicine work?
Personalised medicine expands on the traditional treatment principle by adopting a more data-driven approach. The aim is to tailor treatments more effectively to individual biological and clinical characteristics, rather than relying solely on general recommendations for a specific diagnosis. Depending on the condition, factors such as genetic characteristics, biomarkers, lifestyle and environmental factors may be taken into account.
The process often begins with a comprehensive collection of data through various tests. This means that the diagnosis can be made much more accurately, as laboratory tests and DNA analyses are carried out before a patient receives a specific treatment, in order to identify so-called biomarkers. Biomarkers are biological characteristics such as blood pressure, body temperature, hormones or proteins, which can indicate whether there are signs of a disease, whether a person is at risk of a particular condition, how a disease is likely to progress, or whether a specific treatment is likely to be effective.
Genetics also plays a very important role in personalised medicine. Among other things, research is carried out into how differences in genetic makeup influence the risk of disease or the response to medication. Important sub-fields here are pharmacogenetics and pharmacogenomics. With their help, it is possible to identify how individual gene variants influence the effect, metabolism and tolerability of medicines in the body, and why the same medicine may work very well for one person, have no effect on another, and lead to severe side effects in yet others. Similarly, the optimal dose can be determined before the medicine is administered.
For targeted therapies, specific mutations in a tumour are investigated, for example in oncology. Tumour cells may exhibit certain genetic or molecular alterations for which targeted medicines are available. Similarly, based on this information, unnecessary treatments can be avoided, as it also reveals whether, for example, chemotherapy is likely to be of any benefit at all.
Personalised medicine can also play a role in prevention and early detection. If, for example, hereditary genetic changes are identified that significantly increase the risk of certain cancers, individually tailored early detection or preventive measures can be recommended.

Where is personalised medicine already being used today?
Personalised medicine is already being used in several areas today:
- Oncology: Cancer medicine is one of the most advanced fields of personalised medicine. This involves, for example, using molecular genetic analyses of tumour tissue or blood to identify individual genetic mutations, so that treatment can then be targeted specifically at the cells responsible for tumour development and growth. This is the case, for example, with certain forms of breast cancer or lung cancer. In this context, the term targeted therapy is used. Even during treatment, molecular tests can help to detect changes in the tumour or potential resistance and to adjust the therapy accordingly. One option is what is known as a liquid biopsy. This involves, for example, analysing components of tumour DNA that enter the bloodstream. Methods such as digital PCR or next-generation sequencing can detect such changes.
- Cardiology: Genetic testing can also play a role in the case of hereditary cardiovascular risk factors. One example is familial hypercholesterolaemia, a lipid metabolism disorder that is usually hereditary, in which LDL cholesterol levels may be significantly elevated from birth. This increases the risk of premature atherosclerosis and heart attack. Genetic testing makes it possible to identify, amongst patients with familial hypercholesterolaemia, those who are at particularly high risk, and they are then prescribed targeted medication rather than standard statins.
- Infectious diseases: One example of the effectiveness of genetic testing in determining drug therapy is the assessment of HIV resistance in the HI virus, which can lead to AIDS. By analysing the HIV genome, resistance to specific drug treatments can also be identified. If this is the case, the treatment is adjusted. The tolerability of HIV drugs can also be determined through DNA analysis, as some of these medicines, whilst highly effective, can cause severe or even life-threatening side effects in people who carry a specific gene.
- Rare diseases (orphan diseases): More than 70 per cent of rare diseases have a genetic origin. Genome sequencing can identify the specific mutation in the genome, targeted therapies can be administered, and so-called orphan drugs (medicines for rare diseases) can be developed; alternatively, existing active substances can be screened specifically for molecular mechanisms of action for very small patient groups.
- Pharmacogenetics: Analysing a person’s pharmacogenetic characteristics is a key factor in deciding which medicine to use and at what dosage. This is because the way in which a particular medicine is metabolised, and the rate at which this occurs, varies from person to person. For example, some medicines may be broken down and excreted more quickly in patients with rapid liver metabolism, which also means that these medicines may be less effective in certain cases. Conversely, an active ingredient may have an excessive or even toxic effect in rapid metabolisers. To analyse this, a simple swab of the cheek mucosa or a blood sample is taken and the results are analysed in the laboratory. If a person’s pharmacogenetic characteristics are taken into account, it is possible to ‘predict’ how a medicine will affect a specific individual, adjust the dose accordingly and prevent unwanted side effects.
What are the prospects for personalised medicine?
Personalised medicine opens up new possibilities in the three core areas of prevention, diagnosis and treatment:
- More accurate diagnosis and early detection: Analysing specific genes and biomarkers can help to identify disease risks at an early stage or to classify conditions more precisely. This allows preventive and early-detection measures to be tailored more effectively to specific risk groups.
- Pharmacogenetics: Genetic testing can determine which medicine, and in what dosage, is suitable for a particular patient. This eliminates the need for trial and error when trying out different medicines.
- Targeted therapies: Targeted therapy precisely targets the ‘causes’ of diseases. This enables significantly higher cure rates and survival chances to be achieved, particularly in cancer treatment.
- Fewer side effects: If individual risk factors are taken into account when selecting and dosing medicines, adverse effects can be reduced for certain treatments, or particularly high-risk medicines can be avoided.
- Advances in rare diseases: Many rare diseases have a genetic cause. An accurate genetic diagnosis can help to determine the cause of a disease and, for some conditions, pave the way for targeted therapies. Gene-based therapies are now also available for a growing number of rare genetic diseases.

Where are the limits?
Personalised medicine offers great opportunities, but also presents many challenges:
- Costs: Comprehensive genetic testing and the development of corresponding medicines and treatments also incur very high costs. This places a strain on the healthcare system and may, under certain circumstances, lead to a two-tier healthcare system.
- Data protection: Genetic and other health data are particularly sensitive. They must be protected accordingly, as misuse or unauthorised disclosure can have significant consequences for those affected.
- Complex diseases: Many diseases evolve dynamically, and resistance to targeted therapies can develop. Furthermore, even genetic analyses cannot account for everything that plays a causal role in a disease.
- Research evidence: The approval of new therapeutic agents requires large-scale clinical trials to demonstrate that a particular medicine is effective and safe. Personalised medicine, however, divides patients into smaller subgroups, meaning that the number of participants in such trials is also reduced.
- Technical requirements: Analysing large volumes of genetic and other medical data requires suitable laboratory methods, high-performance bioinformatics systems and the relevant specialist expertise. These prerequisites are not equally available everywhere.
- Training and continuing professional development: Doctors and other healthcare professionals must be able to interpret genetic and molecular findings correctly and assess their significance for diagnosis and treatment. This requires appropriate knowledge and continuing professional development.
When is a genetic test advisable?
A genetic test may be advisable
- if a genetically caused condition is suspected,
- if certain hereditary conditions or types of cancer occur frequently or at an unusually early age in the family,
- if unexplained symptoms may have a genetic cause,
- before starting personalised cancer treatment,
- if you wish to assess the risk of disorders in the embryo during pregnancy,
- when planning to have children, if a hereditary condition is known to run in the family or there is an increased risk of passing on a relevant gene variant,
- if you wish to avoid severe side effects from medication.

How does a genetic test work?
A genetic test is usually straightforward for the person being tested. All that is usually required is a DNA sample from saliva or blood (a swab from the oral mucosa or a blood sample). For specific tests carried out during pregnancy, amniotic fluid or cells from the placenta may also be examined. The sample is then analysed in the laboratory. Depending on the specific question being investigated, the analysis may look specifically for certain genetic changes or examine a larger section of the genome.
It is also important – and mandatory in Austria for medical genetic testing – to have a consultation with a specialist doctor who will discuss and explain the results.
How much does a genetic test cost?
If a genetic test is medically necessary, the costs are usually covered by statutory health insurance in Austria. This is subject to there being a valid medical indication. Depending on the test, a doctor’s referral or authorisation from the health insurance provider may be required. For certain services, excesses or co-payments may also apply.
This may be the case, for example, if a genetically caused condition is suspected or if certain hereditary conditions run in a family. Anyone who has a genetic test carried out privately without a medical indication will usually have to bear the costs themselves. The exact cost depends largely on which genes or sections of the genome are being tested and how comprehensive the analysis is.
Genetic or DNA tests from the internet
Genetic tests and DNA analyses are widely available online. Simple genetic tests are not expensive, and all you need to do is send in a saliva sample, which is then analysed in a laboratory. However, no specialist advice is provided on the results, and experts advise caution, particularly with tests designed to assess health risks, as many of these services can only provide probabilistic information; furthermore, a disease is rarely attributable solely to genetic causes. A test result that is not properly explained may therefore do more harm than good, as there are no clear certainties.
What role does artificial intelligence play in personalised medicine?
Personalised medicine works with large and complex datasets. Artificial intelligence can help to identify patterns and link different pieces of medical information together. Potential applications include the following areas:
- Diagnostics and image analysis: AI-supported methods can assist radiologists and pathologists in the interpretation of medical images. For example, they can identify and quantify specific abnormalities or features that are relevant for diagnosis or treatment planning.
- Predictions regarding disease progression and treatment: When fed with appropriate data, AI models can predict disease progression and treatment outcomes, as they can, where necessary, compare a patient’s profile with millions of anonymised disease histories and thus identify the treatment with the highest response rates and the fewest side effects.
- Early detection: AI can help to identify early signs of disease in certain examinations – for example, when analysing medical images. This could, in some cases, lead to diseases being detected at an earlier stage.
- Drug development: AI can support various stages of drug development, such as the search for new active substances, targets or biomarkers. It can also play a role in research into individually tailored therapies and dosages.
Which doctor should I consult?
Personalised medicine is not a separate medical specialism. Depending on the condition and the specific issue, different specialists or specialist centres may be responsible. In the case of cancer, for example, these may be oncology centres; for rare diseases, specialist centres of expertise; and for chronic conditions such as cardiovascular or rheumatic diseases, the relevant specialists.
If you would like genetic counselling or wish to find out whether a genetic test would be appropriate, you can contact specialists or centres for medical genetics. If you would like to know whether a personalised treatment approach is an option for your condition, your GP is often a good first point of contact. They can assess your symptoms and, if necessary, refer you to the appropriate specialists.